GDelaney,Pretty much agree, I am a nervous holder and won't be...

GDelaney,

Pretty much agree, I am a nervous holder and won't be bappy until it's a done deal but a few things give me encouragement:
1. Indicative pricing like this follows market soundings. It is very embarrassing to list below the target range although it happens). Even if it does, I am encouraged they went this high.
2. The recruitment for the clinical trial is well advanced, maybe will be fully recruited by year end or soon afterwards. This will help the share price post listing.
3. I think (perhaps hope is a better word?) the fonda revenues will be better than the market expects.

Anyway, an interesting couple of months to come!